Molina Healthcare (NYSE: MOH) reported Q4 EPS of $3.07, $1.55 better than the analyst estimate of $1.52. Revenue for the quarter came in at $4.66 billion versus the consensus estimate of $4.55 billion.

• Net income per diluted share on a GAAP basis was $3.01 in the fourth quarter of 2018 and $10.61 for the year ended December 31, 2018
• Fourth quarter 2018 results include a net charge of $0.81 per diluted share, and 2018 results include a net charge of $0.22 per diluted share, for non-run-rate items
• The overall medical care ratio in the fourth quarter improved to 84.6% from 86.4%, sequentially, when excluding non-run rate items
• After-tax margin was 4.3% in the fourth quarter and 3.7% for the full-year 2018
• The Company issued 2019 guidance of $9.25 - $9.75 net income per diluted share on a GAAP basis, which does not include any prior-period reserve development

“We have accomplished much over the last year as we executed the first phase of our margin recovery and sustainability plan,” said Joe Zubretsky, president and CEO. “Our full year results are a capstone to a very successful beginning of this margin turnaround and growth story.

“Our guidance for 2019 reflects continued strength as we sustain our margins while beginning to execute the growth phase of our strategy.”

GUIDANCE:

Molina Healthcare sees FY2019 EPS of $9.25-$9.75, versus the consensus of $9.29. Molina Healthcare sees FY2019 revenue of $16.3 billion, versus the consensus of $17.21 billion.

For earnings history and earnings-related data on Molina Healthcare (MOH) click here.